Napredna pretraga

Pregled bibliografske jedinice broj: 99831

Cellular and Humoral Immunity to Purified Protein Derivative (PPD) in PPD Skin Reactive and Nonreactive Patients with Pulmonary Tuberculosis: Comparative Analysis of Antigen-specific Lymphocyte Proliferation and IgG Antibodies


Boras, Zagorka; Juretić, Antonio; Rudolf, Marija; Užarević, Branka; Treščec, Anđa
Cellular and Humoral Immunity to Purified Protein Derivative (PPD) in PPD Skin Reactive and Nonreactive Patients with Pulmonary Tuberculosis: Comparative Analysis of Antigen-specific Lymphocyte Proliferation and IgG Antibodies // Croatian Medical Journal, 43 (2002), 3; 301-305 (međunarodna recenzija, članak, znanstveni)


Naslov
Cellular and Humoral Immunity to Purified Protein Derivative (PPD) in PPD Skin Reactive and Nonreactive Patients with Pulmonary Tuberculosis: Comparative Analysis of Antigen-specific Lymphocyte Proliferation and IgG Antibodies

Autori
Boras, Zagorka ; Juretić, Antonio ; Rudolf, Marija ; Užarević, Branka ; Treščec, Anđa

Izvornik
Croatian Medical Journal 43 (2002), 3; 301-305

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Antibody specificity; IgG; immunity; T-lymphocytes; tuberculin test; tuberculosis; pulmonary

Sažetak
Aim. To evaluate in vitro reactivity against tuberculin purified protein derivative (PPD) in patients with active pulmonary tuberculosis scoring either positive or negative upon intradermal PPD application (PPD-DTH). Method. Two groups of patients with pulmonary tuberculosis, 22 PPD+ and 22 PPD-, were studied. Peripheral blood mononuclear cells (PBMC) were assayed for in vitro proliferation to PPD antigen, phytohaemagglutin, concanavalin A, and pokeweed mitogens. In the proliferation assay PBMC were incubated in a medium supplemented with serum (20% concentration) from healthy donors, autologous serum, or allogenic serum. Anti-PPD IgG concentration in patients&#8217 ; ; sera were analyzed by ELISA. CD3+ lymphocytes from 10 patients in each group were tested for the expression of surface activation markers (HLA-DR and CD25/IL-2 receptors) by flow cytometry. Results. PPD- patients showed clinically and radiologically more advanced forms of pulmonary tuberculosis as compared with PPD+ patients. PBMC from both groups of patients proliferated in response to PPD effectively, but significantly higher de novo DNA synthesis was observed in PPD+ patients (p<0.001). Proliferative activity was not affected by the type of the serum supplement (autologous or allogenic) in the culture medium. Mitogen stimulation elicited similar proliferative responses in both groups. Similar percentages of T-lymphocytes and T-lymphocytes expressing CD25 activation markers were observed in both groups of patients. There was a borderline difference in the percentage of CD3+HLA-DR+ lymphocytes between these two groups of patients (p=0.05). At 1:1000 serum dilution a significant difference (p=0.002) in anti-PPD IgG concentrations was found between PPD- and PPD+ patients. Conclusion. Patients with active pulmonary tuberculosis with a more favorable clinical course have a more potent specific cell-mediated immunity to PPD (positive skin reactivity in vivo and significantly greater lymphocyte proliferative response in vitro) than patients with a clinically more severe form of the disease. The concentration of PPD specific IgG in the serum appears to be higher in patients with relatively more severe forms of the disease.

Izvorni jezik
Engleski

Znanstvena područja
Javno zdravstvo i zdravstvena zaštita, Dentalna medicina



POVEZANOST RADA


Projekt / tema
074001
108201

Ustanove
Klinika za tumore,
Medicinski fakultet, Zagreb

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • SCI-EXP, SSCI i/ili A&HCI